Patents Assigned to Oneday—Biotech And Pharma Ltd.
  • Glutathione-elevating compositions and uses thereof
    Patent number: 9493507
    Abstract: Use of synthetic thiol-containing peptides as highly effective therapeutic and protective agents is described, in clinical and research applications where lifespan and/or viability and functioning of cells is compromised at least partially due to depletion of reduced glutathione, or where viability and functioning of cells can be improved by elevating reduced glutathione levels. More specifically, compositions and methods for treating blood disorders associated with glutathione dysregulation utilizing short thiol-containing peptides selected from the group consisting of Cys-Lys-Met-Cys (SEQ ID NO: 1), Cys-Met-Lys-Cys (SEQ ID NO: 2) and Cys-?-Ala-His-Cys (SEQ ID NO: 3) are described. Further described are compositions and methods for preserving biological samples using the peptides.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: November 15, 2016
    Assignee: ONEDAY—BIOTECH AND PHARMA LTD.
    Inventor: Josef Mograbi
  • Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
    Patent number: 9034824
    Abstract: Potent compounds having combined antioxidant, anti-inflammatory, anti-radiation and metal chelating properties are described. Short peptides having these properties, and methods and uses of such short peptides in clinical and cosmetic applications are described.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: May 19, 2015
    Assignees: ONEDAY—BIOTECH AND PHARMA LTD., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Josef Mograbi, Daphne Atlas, Shoshana Keynan
  • Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
    Patent number: 8802635
    Abstract: Potent compounds having combined antioxidant, anti-inflammatory, anti-radiation and metal chelating properties are described. Short peptides having these properties, and methods and uses of such short peptides in clinical and cosmetic applications are described.
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: August 12, 2014
    Assignees: Oneday—Biotech And Pharma Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Josef Mograbi, Daphne Atlas, Shoshana Keynan